Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Prospective National-Base Multicenter Study to Standardize the Follow-up of Type 1Gaucher Disease Patients Treated with Eliglustat Under Standard of Care Practice. Trazelga Project

Marcio M Andrade-Campos, PhD, Jorge J Cebolla, MSc, Laura Lopez de Frutos, PhD, Pilar Irun, PhD, Soledad Noya, MD, Santiago Nieto, MD, Lucia Villalon, PhD, Ana I Arribas, MD, Abelardo Barez, PhD, Javier Garcia-Frade, PD, Maria Lourdes Hermosin, MD, Jesús-María Hernández-Rivas, MD PhD, Daiana Ibarretxe, MD, Maria L Lozano, MD PhD, Teresa Molero, PhD, Maria Angeles Perez-Saenz, MDPhD, Jesus Villarrubia, PhD, Pilar Giraldo, PhD

Blood (2018) 132 (Supplement 1): 4942.

https://doi.org/10.1182/blood-2018-99-115534

Published: 2018

Journal Articles

Early Diagnosis of an Infant with Gaucher's Disease Type 3. Case Report

Adriana C. Bello, MD, Rossana Cortez

Blood (2018) 132 (Supplement 1): 4950.

https://doi.org/10.1182/blood-2018-99-110263

Published: 2018

Journal Articles

Health-Related Quality of Life of Twenty-Seven Patients with Gaucher Disease Type I in China

Hongmin Li, PhD, Yuan Li, Zhangbiao Long, MD, Yali Du, Miao Chen, Junling Zhuang, Zhengqing Qiu, Zhao Wang, MD PhD, Bing Han

Blood (2017) 130 (Supplement 1): 4812.

https://doi.org/10.1182/blood.V130.Suppl_1.4812.4812

Published: 2017

Journal Articles

Proinflammatory Cytokines Profile, a Link Between Multiple Myeloma and Gaucher Disease

Javier Gervas, PhD, Marcio M Andrade, MD, Pilar Giraldo

Blood (2014) 124 (21): 4952.

https://doi.org/10.1182/blood.V124.21.4952.4952

Published: 2014

Journal Articles

Novel Management of Immune Thrombocytopenia in Gaucher Disease Patients

Hanna Rosenbaum, MD

Blood (2014) 124 (21): 5006.

https://doi.org/10.1182/blood.V124.21.5006.5006

Published: 2014

Journal Articles

Persistence of Imiglucerase in Cell Compartment Explains Dosing Frequency of Every Two Weeks in Type 1 Gaucher Disease

Juliette Berger, PhD, Marie Vigan, PhD, Jérôme Stirnemann, PD, PhD Professor, Céline Bourgne, PhD, Alexandre Janel, PhD, Nadia Belmatoug, MD, Christian Rose, MD, Monia Bengherbia, Bruno Pereira, France Mentré, MD PhD Professor, Marc G Berger, MD PhD

Blood (2014) 124 (21): 1396.

https://doi.org/10.1182/blood.V124.21.1396.1396

Published: 2014

Journal Articles

A Multicenter Observational Study For Early Diagnosis Of Gaucher Disease In Patients With Splenomegaly and/Or Thrombocytopenia

Irene Motta, MD, Mirella Filocamo, BSc, PhD, Marina Stroppiano, BSc, PhD, Erika Poggiali, MD, Alfredo Dragani, MD, Maria Domenica, MD

Blood (2013) 122 (21): 4712.

https://doi.org/10.1182/blood.V122.21.4712.4712

Published: 2013

Journal Articles

Replacement Therapy with Imiglucerase Improves Magnetic Resonance Imaging (MRI) Abnormalities in Almost Half Patients with Non-Neuronopathic Form of Gaucher Disease After Twelve Months of Therapy: Results of a Semi-Quantitative MRI Method.

Veroniki Komninaka, Dionysia Kolomodi, Theodore Marinakis, Konstantina Repa, Dimitrios Christoulas, Ersi Voskaridou, Meletios A Dimopoulos, MD, Evangelos Terpos

Blood (2012) 120 (21): 2132.

https://doi.org/10.1182/blood.V120.21.2132.2132

Published: 2012

Journal Articles

Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis

Sarah M. Lo, Murim Choi, Jun Liu, Dhanpat Jain, Rolf G. Boot, Wouter W. Kallemeijn, Johannes M. F. G. Aerts, Farzana Pashankar, Gary M. Kupfer, Shrikant Mane, Richard P. Lifton, Pramod K. Mistry

Blood (2012) 119 (20): 4731–4740.

https://doi.org/10.1182/blood-2011-10-386862

Published: 2012

Journal Articles

Bone Involvement in Patients with Non-Neuronopathic Gaucher Disease Is Characterized by Increased Osteoclast Function Partially Due to High Circulating C-C Motif Ligand 3,

Veroniki Komninaka, Theodore Marinakis, Dimitrios Christoulas, Konstantina Repa, Dionysia Kolomodi, Maria Mitropoulou, Maria Gkotzamanidou, Athanasios Papatheodorou, Nikolaos Anagnostopoulos, Meletios Athanasios Dimopoulos, MD, Evangelos Terpos

Blood (2011) 118 (21): 3215.

https://doi.org/10.1182/blood.V118.21.3215.3215

Published: 2011

Journal Articles

Gaucher Disease and LGL Proliferations: Provocative Commonality?

Rosa Ruchlemer, MD, Deborah Elstein, PhD, Eti Broide, Constantine Reinus, Hannah Maayaan, Ari Zimran, MD

Blood (2011) 118 (21): 1100.

https://doi.org/10.1182/blood.V118.21.1100.1100

Published: 2011

Journal Articles

Immune Thrombocytopenia in Type I Gaucher Disease.

Hanna Rosenbaum, MD, Tina Napso, MS.c, Lilach Bonstein, Ph.D

Blood (2007) 110 (11): 3200.

https://doi.org/10.1182/blood.V110.11.3200.3200

Published: 2007

Journal Articles

Long-Term Follow-Up of Monoclonal Gammopathies in Gaucher Disease Patients on Enzyme Replacement Therapy.

Jae H. Park, MD, Allan F. Moore, MD, David J. Kuter, MD, DPhil

Blood (2006) 108 (11): 3336.

https://doi.org/10.1182/blood.V108.11.3336.3336

Published: 2006

Journal Articles

Autoimmunity and Hypercoagulability in Anderson Fabry Patients from Argentina.

Mario C. Aggio, MD, Pablo A. Martinez, PhD

Blood (2005) 106 (11): 4115.

https://doi.org/10.1182/blood.V106.11.4115.4115

Published: 2005

Journal Articles

Gaucher disease and cancer incidence: a study from the Gaucher Registry

Barry E. Rosenbloom, Neal J. Weinreb, Ari Zimran, Katherine A. Kacena, Joel Charrow, Elizabeth Ward

Blood (2005) 105 (12): 4569–4572.

https://doi.org/10.1182/blood-2004-12-4672

Published: 2005

Journal Articles

Glucocerebroside Alleviates Chronic Graft-Versus-Host-Disease in a Murine Model.

Arnon Nagler, Maya Margalit, Meir Ohana, Ruslana Alper, Orit Pappo, Elazar Rabbani, Dean Engelhart, Yaron Ilan

Blood (2004) 104 (11): 4965.

https://doi.org/10.1182/blood.V104.11.4965.4965

Published: 2004

Journal Articles

Thrombophylic Profile of Fabry Patients in Argentina.

Mario C. Aggio, MD, Pablo A. Martinez, PhD

Blood (2004) 104 (11): 4048.

https://doi.org/10.1182/blood.V104.11.4048.4048

Published: 2004

Journal Articles

Peripheral Blood Dendritic Cell Subsets of Patients with Type I Gaucher’s Disease Are Decreased in Number but Functionally Normal.

Argiris Symeonidis, Ilina Mitseva, Theodoros Marinakis, Constantina Repa, Alexandra Kouraklis, Nikolaos Anagnostopoulos, Nicholas Zoumbos

Blood (2004) 104 (11): 3810.

https://doi.org/10.1182/blood.V104.11.3810.3810

Published: 2004

Journal Articles

Detection and Isolation of Gene-Corrected Cells in Gaucher Disease Via a Fluorescence-Activated Cell Sorter Assay for Lysosomal Glucocerebrosidase Activity

Matthew Lorincz, Leonard A. Herzenberg, Zhenjun Diwu, John A. Barranger, William G. Kerr

Blood (1997) 89 (9): 3412–3420.

https://doi.org/10.1182/blood.V89.9.3412

Published: 1997

NARROW

Prospective National-Base Multicenter Study to Standardize the Follow-up of Type 1Gaucher Disease Patients Treated with Eliglustat Under Standard of Care Practice. Trazelga Project

Early Diagnosis of an Infant with Gaucher's Disease Type 3. Case Report

Health-Related Quality of Life of Twenty-Seven Patients with Gaucher Disease Type I in China

Proinflammatory Cytokines Profile, a Link Between Multiple Myeloma and Gaucher Disease

Novel Management of Immune Thrombocytopenia in Gaucher Disease Patients

Persistence of Imiglucerase in Cell Compartment Explains Dosing Frequency of Every Two Weeks in Type 1 Gaucher Disease

A Multicenter Observational Study For Early Diagnosis Of Gaucher Disease In Patients With Splenomegaly and/Or Thrombocytopenia

Replacement Therapy with Imiglucerase Improves Magnetic Resonance Imaging (MRI) Abnormalities in Almost Half Patients with Non-Neuronopathic Form of Gaucher Disease After Twelve Months of Therapy: Results of a Semi-Quantitative MRI Method.

Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis

Bone Involvement in Patients with Non-Neuronopathic Gaucher Disease Is Characterized by Increased Osteoclast Function Partially Due to High Circulating C-C Motif Ligand 3,

Gaucher Disease and LGL Proliferations: Provocative Commonality?

Immune Thrombocytopenia in Type I Gaucher Disease.

Long-Term Follow-Up of Monoclonal Gammopathies in Gaucher Disease Patients on Enzyme Replacement Therapy.

Autoimmunity and Hypercoagulability in Anderson Fabry Patients from Argentina.

Gaucher disease and cancer incidence: a study from the Gaucher Registry

Glucocerebroside Alleviates Chronic Graft-Versus-Host-Disease in a Murine Model.

Thrombophylic Profile of Fabry Patients in Argentina.

Peripheral Blood Dendritic Cell Subsets of Patients with Type I Gaucher’s Disease Are Decreased in Number but Functionally Normal.

Detection and Isolation of Gene-Corrected Cells in Gaucher Disease Via a Fluorescence-Activated Cell Sorter Assay for Lysosomal Glucocerebrosidase Activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only